Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Vaccines

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 286 articles:
HTML format
Text format



Single Articles


    January 2017
  1. HUBER B, Schellenbacher C, Shafti-Keramat S, Jindra C, et al
    Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
    PLoS One. 2017;12:e0169533.
    PubMed     Text format     Abstract available


  2. REN ST, Zhang XM, Sun PF, Sun LJ, et al
    Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59.
    PLoS One. 2017;12:e0169501.
    PubMed     Text format     Abstract available


  3. MCCOLLUM ED, Nambiar B, Deula R, Zadutsa B, et al
    Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study.
    PLoS One. 2017;12:e0168209.
    PubMed     Text format     Abstract available


  4. MARTORELLI L, Garbaccio S, Vilte DA, Albanese AA, et al
    Immune Response in Calves Vaccinated with Type Three Secretion System Antigens and Shiga Toxin 2B Subunit of Escherichia coli O157:H7.
    PLoS One. 2017;12:e0169422.
    PubMed     Text format     Abstract available


  5. SLIKE BM, Creegan M, Marovich M, Ngauy V, et al
    Humoral Immunity to Primary Smallpox Vaccination: Impact of Childhood versus Adult Immunization on Vaccinia Vector Vaccine Development in Military Populations.
    PLoS One. 2017;12:e0169247.
    PubMed     Text format     Abstract available


  6. SMETANA J, Chlibek R, Hanovcova I, Sosovickova R, et al
    Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic.
    PLoS One. 2017;12:e0170257.
    PubMed     Text format     Abstract available


  7. HE Y, Sultana I, Takeda K, Reed JL, et al
    Cutaneous Deficiency of Filaggrin and STAT3 Exacerbates Vaccinia Disease In Vivo.
    PLoS One. 2017;12:e0170070.
    PubMed     Text format     Abstract available


  8. LU D, Qiao Y, Brown NE, Wang J, et al
    Racial and Ethnic Disparities in Influenza Vaccination among Adults with Chronic Medical Conditions Vary by Age in the United States.
    PLoS One. 2017;12:e0169679.
    PubMed     Text format     Abstract available


  9. BAWANKULE R, Singh A, Kumar K, Shetye S, et al
    Does Measles Vaccination Reduce the Risk of Acute Respiratory Infection (ARI) and Diarrhea in Children: A Multi-Country Study?
    PLoS One. 2017;12:e0169713.
    PubMed     Text format     Abstract available


  10. LEE HJ, Lee JY, Park MH, Kim JY, et al
    Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases.
    PLoS One. 2017;12:e0169139.
    PubMed     Text format     Abstract available


  11. SERRANO M, Elguezabal N, Sevilla IA, Geijo MV, et al
    Tuberculosis Detection in Paratuberculosis Vaccinated Calves: New Alternatives against Interference.
    PLoS One. 2017;12:e0169735.
    PubMed     Text format     Abstract available


  12. DARVISHIAN M, Dijkstra F, van Doorn E, Bijlsma MJ, et al
    Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes.
    PLoS One. 2017;12:e0169528.
    PubMed     Text format     Abstract available


  13. FALKENHORST G, Remschmidt C, Harder T, Hummers-Pradier E, et al
    Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis.
    PLoS One. 2017;12:e0169368.
    PubMed     Text format     Abstract available


  14. WANG J, Su C, Liu R, Liu B, et al
    A Pre-Clinical Safety Evaluation of SBP (HBsAg-Binding Protein) Adjuvant for Hepatitis B Vaccine.
    PLoS One. 2017;12:e0170313.
    PubMed     Text format     Abstract available


  15. TOSTES RO, Rodrigues TC, da Silva JB, Schanoski AS, et al
    Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.
    PLoS One. 2017;12:e0170157.
    PubMed     Text format     Abstract available


  16. PRAPHASIRI P, Ditsungneon D, Greenbaum A, Dawood FS, et al
    Do Thai Physicians Recommend Seasonal Influenza Vaccines to Pregnant Women? A Cross-Sectional Survey of Physicians' Perspectives and Practices in Thailand.
    PLoS One. 2017;12:e0169221.
    PubMed     Text format     Abstract available


  17. HOWARD LM, Hoek KL, Goll JB, Samir P, et al
    Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled Trial.
    PLoS One. 2017;12:e0167488.
    PubMed     Text format     Abstract available


  18. LI K, Wei G, Cao Y, Li D, et al
    The Identification and Distribution of Cattle XCR1 and XCL1 among Peripheral Blood Cells: New Insights into the Design of Dendritic Cells Targeted Veterinary Vaccine.
    PLoS One. 2017;12:e0170575.
    PubMed     Text format     Abstract available


  19. DE SERRES G, Skowronski DM, Ward BJ, Gardam M, et al
    Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement.
    PLoS One. 2017;12:e0163586.
    PubMed     Text format     Abstract available


  20. HAYWARD AC
    Influenza Vaccination of Healthcare Workers Is an Important Approach for Reducing Transmission of Influenza from Staff to Vulnerable Patients.
    PLoS One. 2017;12:e0169023.
    PubMed     Text format    


  21. SECORE S, Wang S, Doughtry J, Xie J, et al
    Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.
    PLoS One. 2017;12:e0170640.
    PubMed     Text format     Abstract available


  22. SCHMID P, Rauber D, Betsch C, Lidolt G, et al
    Barriers of Influenza Vaccination Intention and Behavior - A Systematic Review of Influenza Vaccine Hesitancy, 2005 - 2016.
    PLoS One. 2017;12:e0170550.
    PubMed     Text format     Abstract available


  23. HJALMARSDOTTIR MA, Quirk SJ, Haraldsson G, Erlendsdottir H, et al
    Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland.
    PLoS One. 2017;12:e0169210.
    PubMed     Text format     Abstract available


  24. GORMLEY E, Ni Bhuachalla D, O'Keeffe J, Murphy D, et al
    Oral Vaccination of Free-Living Badgers (Meles meles) with Bacille Calmette Guerin (BCG) Vaccine Confers Protection against Tuberculosis.
    PLoS One. 2017;12:e0168851.
    PubMed     Text format     Abstract available


  25. MOISI JC, Makawa MS, Tall H, Agbenoko K, et al
    Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine.
    PLoS One. 2017;12:e0170412.
    PubMed     Text format     Abstract available


  26. MA L, Wang X, Bi X, Yang J, et al
    Characteristics Peripheral Blood IgG and IgM Heavy Chain Complementarity Determining Region 3 Repertoire before and after Immunization with Recombinant HBV Vaccine.
    PLoS One. 2017;12:e0170479.
    PubMed     Text format     Abstract available


  27. BURGHOUTS J, Del Nogal B, Uriepero A, Hermans PW, et al
    Childhood Vaccine Acceptance and Refusal among Warao Amerindian Caregivers in Venezuela; A Qualitative Approach.
    PLoS One. 2017;12:e0170227.
    PubMed     Text format     Abstract available


  28. FU Y, Li P, Cao Y, Wang N, et al
    Development of a Blocking ELISA Using a Monoclonal Antibody to a Dominant Epitope in Non-Structural Protein 3A of Foot-and-Mouth Disease Virus, as a Matching Test for a Negative-Marker Vaccine.
    PLoS One. 2017;12:e0170560.
    PubMed     Text format     Abstract available


  29. AIYEGBO MS, Shmelkov E, Dominguez L, Goger M, et al
    Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic alpha-Helical Structure.
    PLoS One. 2017;12:e0170530.
    PubMed     Text format     Abstract available


  30. ELAISH M, Ngunjiri JM, Ali A, Xia M, et al
    Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens.
    PLoS One. 2017;12:e0171174.
    PubMed     Text format     Abstract available


  31. CILVETI R, Olmo M, Perez-Jove J, Picazo JJ, et al
    Epidemiology of Otitis Media with Spontaneous Perforation of the Tympanic Membrane in Young Children and Association with Bacterial Nasopharyngeal Carriage, Recurrences and Pneumococcal Vaccination in Catalonia, Spain - The Prospective HERMES Study.
    PLoS One. 2017;12:e0170316.
    PubMed     Text format     Abstract available


  32. ZHANG X, Mu Y, Mu P, Ao J, et al
    Transcriptome Analysis Reveals Comprehensive Insights into the Early Immune Response of Large Yellow Croaker (Larimichthys crocea) Induced by Trivalent Bacterial Vaccine.
    PLoS One. 2017;12:e0170958.
    PubMed     Text format     Abstract available


  33. ZHANG A, Lai H, Xu J, Huang W, et al
    Evaluation of the Protective Efficacy of Poly I:C as an Adjuvant for H9N2 Subtype Avian Influenza Inactivated Vaccine and Its Mechanism of Action in Ducks.
    PLoS One. 2017;12:e0170681.
    PubMed     Text format     Abstract available


  34. MARANA MH, Jorgensen LV, Skov J, Chettri JK, et al
    Subunit vaccine candidates against Aeromonas salmonicida in rainbow trout Oncorhynchus mykiss.
    PLoS One. 2017;12:e0171944.
    PubMed     Text format     Abstract available


  35. QU F, Weschler LB, Sun Y, Sundell J, et al
    High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination.
    PLoS One. 2017;12:e0171438.
    PubMed     Text format     Abstract available


  36. OVSYANNIKOVA IG, Schaid DJ, Larrabee BR, Haralambieva IH, et al
    A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses.
    PLoS One. 2017;12:e0171261.
    PubMed     Text format     Abstract available


  37. PICAZO J, Ruiz-Contreras J, Casado-Flores J, Negreira S, et al
    Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015.
    PLoS One. 2017;12:e0172222.
    PubMed     Text format     Abstract available


  38. GUTHRIE JL, Fisman D, Gardy JL
    Self-rated health and reasons for non-vaccination against seasonal influenza in Canadian adults with asthma.
    PLoS One. 2017;12:e0172117.
    PubMed     Text format     Abstract available


  39. ROJO JU, Melkus MW, Kottapalli KR, Okiya OE, et al
    Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons.
    PLoS One. 2017;12:e0171677.
    PubMed     Text format     Abstract available


  40. MENG FY, Sun Y, Shen YG, Pan HF, et al
    Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China.
    PLoS One. 2017;12:e0172108.
    PubMed     Text format     Abstract available


  41. DE GROOT AS, Tounkara K, Rochas M, Beseme S, et al
    Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali.
    PLoS One. 2017;12:e0171631.
    PubMed     Text format     Abstract available


  42. DOMINGUEZ A, Soldevila N, Toledo D, Torner N, et al
    Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain.
    PLoS One. 2017;12:e0171943.
    PubMed     Text format     Abstract available


  43. HRADILOVA N, Sadilkova L, Palata O, Mysikova D, et al
    Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy.
    PLoS One. 2017;12:e0171539.
    PubMed     Text format     Abstract available


  44. SALIH DA, Pelle R, Mwacharo JM, Njahira MN, et al
    Genes encoding two Theileria parva antigens recognized by CD8+ T-cells exhibit sequence diversity in South Sudanese cattle populations but the majority of alleles are similar to the Muguga component of the live vaccine cocktail.
    PLoS One. 2017;12:e0171426.
    PubMed     Text format     Abstract available


  45. TEGUETE I, Dolo A, Sangare K, Sissoko A, et al
    Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali.
    PLoS One. 2017;12:e0172661.
    PubMed     Text format     Abstract available


  46. DALGIC OO, Ozaltin OY, Ciccotelli WA, Erenay FS, et al
    Deriving effective vaccine allocation strategies for pandemic influenza: Comparison of an agent-based simulation and a compartmental model.
    PLoS One. 2017;12:e0172261.
    PubMed     Text format     Abstract available


  47. MARIN D, Marin N, Del Corral H, Lopez L, et al
    PPD-induced monocyte mitochondrial damage is associated with a protective effect to develop tuberculosis in BCG vaccinated individuals: A cohort study.
    PLoS One. 2017;12:e0171930.
    PubMed     Text format     Abstract available


  48. HOLUBAR M, Stavroulakis MC, Maldonado Y, Ioannidis JP, et al
    Impact of vaccine herd-protection effects in cost-effectiveness analyses of childhood vaccinations. A quantitative comparative analysis.
    PLoS One. 2017;12:e0172414.
    PubMed     Text format     Abstract available


  49. PALMU AA, Rinta-Kokko H, Nohynek H, Nuorti JP, et al
    Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.
    PLoS One. 2017;12:e0172690.
    PubMed     Text format     Abstract available


  50. GULLBERG M, Lohse L, Botner A, McInerney GM, et al
    Correction: A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    PLoS One. 2017;12:e0173327.
    PubMed     Text format     Abstract available


  51. MORAES-SOUZA RQ, Reinaque AP, Soares TS, Silva AL, et al
    Safety evaluation of a vaccine: Effect in maternal reproductive outcome and fetal anomaly frequency in rats using a leishmanial vaccine as a model.
    PLoS One. 2017;12:e0172525.
    PubMed     Text format     Abstract available


  52. MARTI M, de Cola M, MacDonald NE, Dumolard L, et al
    Assessments of global drivers of vaccine hesitancy in 2014-Looking beyond safety concerns.
    PLoS One. 2017;12:e0172310.
    PubMed     Text format     Abstract available


  53. GALEA JT, Monsour E, Nurena CR, Blas MM, et al
    HPV vaccine knowledge and acceptability among Peruvian men who have sex with men and transgender women: A pilot, qualitative study.
    PLoS One. 2017;12:e0172964.
    PubMed     Text format     Abstract available


  54. WEN G, Li L, Yu Q, Wang H, et al
    Evaluation of a thermostable Newcastle disease virus strain TS09-C as an in-ovo vaccine for chickens.
    PLoS One. 2017;12:e0172812.
    PubMed     Text format     Abstract available


  55. CHAPMAN R, Jongwe TI, Douglass N, Chege G, et al
    Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice.
    PLoS One. 2017;12:e0173352.
    PubMed     Text format     Abstract available


  56. ISLAM MA, Grosse-Brinkhaus C, Proll MJ, Uddin MJ, et al
    PBMC transcriptome profiles identifies potential candidate genes and functional networks controlling the innate and the adaptive immune response to PRRSV vaccine in Pietrain pig.
    PLoS One. 2017;12:e0171828.
    PubMed     Text format     Abstract available


  57. DAYER JA, Siegrist CA, Huttner A
    Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous survey.
    PLoS One. 2017;12:e0173148.
    PubMed     Text format     Abstract available


  58. TEFERI WM, Desaulniers MA, Noyce RS, Shenouda M, et al
    The vaccinia virus K7 protein promotes histone methylation associated with heterochromatin formation.
    PLoS One. 2017;12:e0173056.
    PubMed     Text format     Abstract available


  59. HEQUET D, Rouzier R
    Determinants of geographic inequalities in HPV vaccination in the most populated region of France.
    PLoS One. 2017;12:e0172906.
    PubMed     Text format     Abstract available


  60. KIM JI, Lee I, Park S, Bae JY, et al
    Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea.
    PLoS One. 2017;12:e0172059.
    PubMed     Text format     Abstract available


  61. ESQUERRE M, Bouillette-Marussig M, Goubier A, Momot M, et al
    GTL001, a bivalent therapeutic vaccine against human papillomavirus 16 and 18, induces antigen-specific CD8+ T cell responses leading to tumor regression.
    PLoS One. 2017;12:e0174038.
    PubMed     Text format     Abstract available


  62. LAURENS MB, Kouriba B, Bergmann-Leitner E, Angov E, et al
    Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine.
    PLoS One. 2017;12:e0173294.
    PubMed     Text format     Abstract available


  63. LU W, Wan Y, Ma F, Johnson RP, et al
    Distinct transcriptome profiles of Gag-specific CD8+ T cells temporally correlated with the protection elicited by SIVDeltanef live attenuated vaccine.
    PLoS One. 2017;12:e0173929.
    PubMed     Text format     Abstract available


  64. PEREIRA SR, Pereira R, Figueiredo I, Freitas V, et al
    Comparison of anti-inflammatory activities of an anthocyanin-rich fraction from Portuguese blueberries (Vaccinium corymbosum L.) and 5-aminosalicylic acid in a TNBS-induced colitis rat model.
    PLoS One. 2017;12:e0174116.
    PubMed     Text format     Abstract available


  65. SALISCH NC, Vujadinovic M, van der Helm E, Spek D, et al
    Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform.
    PLoS One. 2017;12:e0174728.
    PubMed     Text format     Abstract available


  66. KIM SH, Chen Z, Yoshida A, Paldurai A, et al
    Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines.
    PLoS One. 2017;12:e0173965.
    PubMed     Text format     Abstract available


  67. CAMARA J, Marimon JM, Cercenado E, Larrosa N, et al
    Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain.
    PLoS One. 2017;12:e0175224.
    PubMed     Text format     Abstract available


  68. LEE JY, Chang J
    Universal vaccine against respiratory syncytial virus A and B subtypes.
    PLoS One. 2017;12:e0175384.
    PubMed     Text format     Abstract available


  69. HAUKE CA, Taylor RK
    Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus.
    PLoS One. 2017;12:e0175170.
    PubMed     Text format     Abstract available


  70. SHIM E
    Cost-effectiveness of dengue vaccination in Yucatan, Mexico using a dynamic dengue transmission model.
    PLoS One. 2017;12:e0175020.
    PubMed     Text format     Abstract available


  71. VERMA S, Soto J, Vasudevan A, Schmeisser F, et al
    Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies.
    PLoS One. 2017;12:e0175733.
    PubMed     Text format     Abstract available


  72. GASPARINHO C, Piedade J, Mirante MC, Mendes C, et al
    Characterization of rotavirus infection in children with acute gastroenteritis in Bengo province, Northwestern Angola, prior to vaccine introduction.
    PLoS One. 2017;12:e0176046.
    PubMed     Text format     Abstract available


  73. GRANDAHL M, Larsson M, Tyden T, Stenhammar C, et al
    School nurses' attitudes towards and experiences of the Swedish school-based HPV vaccination programme - A repeated cross sectional study.
    PLoS One. 2017;12:e0175883.
    PubMed     Text format     Abstract available


  74. KREIZINGER Z, Sulyok KM, Grozner D, Beko K, et al
    Development of mismatch amplification mutation assays for the differentiation of MS1 vaccine strain from wild-type Mycoplasma synoviae and MS-H vaccine strains.
    PLoS One. 2017;12:e0175969.
    PubMed     Text format     Abstract available


  75. BORTHWICK N, Lin Z, Akahoshi T, Llano A, et al
    Novel, in-natural-infection subdominant HIV-1 CD8+ T-cell epitopes revealed in human recipients of conserved-region T-cell vaccines.
    PLoS One. 2017;12:e0176418.
    PubMed     Text format     Abstract available


  76. DELEA TE, Weycker D, Atwood M, Neame D, et al
    Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.
    PLoS One. 2017;12:e0175721.
    PubMed     Text format     Abstract available


  77. JACKWOOD MW, Lee DH
    Different evolutionary trajectories of vaccine-controlled and non-controlled avian infectious bronchitis viruses in commercial poultry.
    PLoS One. 2017;12:e0176709.
    PubMed     Text format     Abstract available


  78. WIJNANS L, Dodd CN, Weibel D, Sturkenboom M, et al
    Bell's palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series.
    PLoS One. 2017;12:e0175539.
    PubMed     Text format     Abstract available


  79. SIMOES MJ, Bettencourt C, De Paola R, Giuliani M, et al
    Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal.
    PLoS One. 2017;12:e0176177.
    PubMed     Text format     Abstract available


  80. TKACHUK AP, Gushchin VA, Potapov VD, Demidenko AV, et al
    Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models.
    PLoS One. 2017;12:e0176784.
    PubMed     Text format     Abstract available


  81. PAULO AC, Sa-Leao R
    Periodic cycles of pneumococcal serotypes carried by children before and after 7-valent pneumococcal conjugate vaccine.
    PLoS One. 2017;12:e0176723.
    PubMed     Text format     Abstract available


  82. HEO JY, Seo YB, Choi WS, Lee J, et al
    Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea.
    PLoS One. 2017;12:e0177342.
    PubMed     Text format     Abstract available


  83. VON REYN CF, Lahey T, Arbeit RD, Landry B, et al
    Safety and immunogenicity of an inactivated whole cell tuberculosis vaccine booster in adults primed with BCG: A randomized, controlled trial of DAR-901.
    PLoS One. 2017;12:e0175215.
    PubMed     Text format     Abstract available


  84. GILBERT PB, Excler JL, Tomaras GD, Carpp LN, et al
    Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women.
    PLoS One. 2017;12:e0176428.
    PubMed     Text format     Abstract available


  85. VAN AALST S, Ludwig IS, van der Zee R, van Eden W, et al
    Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant.
    PLoS One. 2017;12:e0177365.
    PubMed     Text format     Abstract available


  86. HAUSE AM, Henke DM, Avadhanula V, Shaw CA, et al
    Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
    PLoS One. 2017;12:e0175792.
    PubMed     Text format     Abstract available


  87. MORTENSEN R, Christensen D, Hansen LB, Christensen JP, et al
    Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes.
    PLoS One. 2017;12:e0175707.
    PubMed     Text format     Abstract available


  88. TALLMADGE RL, Miller SC, Parry SA, Felippe MJB, et al
    Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.
    PLoS One. 2017;12:e0177831.
    PubMed     Text format     Abstract available


    January 2016
  89. WIJMENGA-MONSUUR AJ, van Westen E, Knol MJ, Jongerius RM, et al
    Correction: Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.
    PLoS One. 2016;11:e0155088.
    PubMed     Text format     Abstract available


  90. COSGROVE CA, Lacey CJ, Cope AV, Bartolf A, et al
    Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.
    PLoS One. 2016;11:e0152038.
    PubMed     Text format     Abstract available


  91. ZHA J, Chi XW, Yu XL, Liu XM, et al
    Interleukin-1beta-Targeted Vaccine Improves Glucose Control and beta-Cell Function in a Diabetic KK-Ay Mouse Model.
    PLoS One. 2016;11:e0154298.
    PubMed     Text format     Abstract available


  92. MVULA H, Heinsbroek E, Chihana M, Crampin AC, et al
    Predictors of Uptake and Timeliness of Newly Introduced Pneumococcal and Rotavirus Vaccines, and of Measles Vaccine in Rural Malawi: A Population Cohort Study.
    PLoS One. 2016;11:e0154997.
    PubMed     Text format     Abstract available


  93. MARTIN SD, Brown SD, Wick DA, Nielsen JS, et al
    Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines.
    PLoS One. 2016;11:e0155189.
    PubMed     Text format     Abstract available


  94. DEERE JD, Chang WL, Castillo LD, Schmidt KA, et al
    Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS.
    PLoS One. 2016;11:e0155629.
    PubMed     Text format     Abstract available


  95. YU Z, Liu J, Wang X, Zhu X, et al
    Efficient Vaccine Distribution Based on a Hybrid Compartmental Model.
    PLoS One. 2016;11:e0155416.
    PubMed     Text format     Abstract available


  96. LU J, Wu P, Zhang X, Feng L, et al
    Immunopotentiators Improve the Efficacy of Oil-Emulsion-Inactivated Avian Influenza Vaccine in Chickens, Ducks and Geese.
    PLoS One. 2016;11:e0156573.
    PubMed     Text format     Abstract available


  97. ALLEN ER, van Diemen P, Yamaguchi Y, Lindemann C, et al
    MRI Based Localisation and Quantification of Abscesses following Experimental S. aureus Intravenous Challenge: Application to Vaccine Evaluation.
    PLoS One. 2016;11:e0154705.
    PubMed     Text format     Abstract available


  98. STONE J, Martin NK, Hickman M, Hellard M, et al
    The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
    PLoS One. 2016;11:e0156213.
    PubMed     Text format     Abstract available


  99. RAMANATHAN B, Poh CL, Kirk K, McBride WJ, et al
    Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.
    PLoS One. 2016;11:e0155900.
    PubMed     Text format     Abstract available


  100. KHAN SA, Desclozeaux M, Waugh C, Hanger J, et al
    Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants.
    PLoS One. 2016;11:e0156094.
    PubMed     Text format     Abstract available


  101. LAUGHIN RC, Drake KL, Morrill JC, Adams LG, et al
    Correction: Correlative Gene Expression to Protective Seroconversion In Rift Valley Vaccinates.
    PLoS One. 2016;11:e0156469.
    PubMed     Text format     Abstract available


  102. NAVALPAKAM A, Dany M, Hajj Hussein I
    Behavioral Perceptions of Oakland University Female College Students towards Human Papillomavirus Vaccination.
    PLoS One. 2016;11:e0155955.
    PubMed     Text format     Abstract available


  103. VISSER O, Hautvast JL, van der Velden K, Hulscher ME, et al
    Intention to Accept Pertussis Vaccination for Cocooning: A Qualitative Study of the Determinants.
    PLoS One. 2016;11:e0155861.
    PubMed     Text format     Abstract available


  104. ADAMS J, McNaughton RJ, Wigham S, Flynn D, et al
    Acceptability of Parental Financial Incentives and Quasi-Mandatory Interventions for Preschool Vaccinations: Triangulation of Findings from Three Linked Studies.
    PLoS One. 2016;11:e0156843.
    PubMed     Text format     Abstract available


  105. KLUSHKINA VV, Kyuregyan KK, Kozhanova TV, Popova OE, et al
    Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia.
    PLoS One. 2016;11:e0157161.
    PubMed     Text format     Abstract available


  106. FULLEN DJ, Noulin N, Catchpole A, Fathi H, et al
    Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
    PLoS One. 2016;11:e0157211.
    PubMed     Text format     Abstract available


  107. DOWALL SD, Graham VA, Rayner E, Hunter L, et al
    Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses.
    PLoS One. 2016;11:e0156637.
    PubMed     Text format     Abstract available


  108. LOMBARDI F, Belmonti S, Fabbiani M, Morandi M, et al
    Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study.
    PLoS One. 2016;11:e0156523.
    PubMed     Text format     Abstract available


  109. JANG H, Ngunjiri JM, Lee CW
    Association between Interferon Response and Protective Efficacy of NS1-Truncated Mutants as Influenza Vaccine Candidates in Chickens.
    PLoS One. 2016;11:e0156603.
    PubMed     Text format     Abstract available


  110. MICHEL G, Ferrua B, Munro P, Boyer L, et al
    Immunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantum.
    PLoS One. 2016;11:e0156363.
    PubMed     Text format     Abstract available


  111. DUBE E, Gagnon D, Ouakki M, Bettinger JA, et al
    Understanding Vaccine Hesitancy in Canada: Results of a Consultation Study by the Canadian Immunization Research Network.
    PLoS One. 2016;11:e0156118.
    PubMed     Text format     Abstract available


  112. MCNEILLY C, Cosh S, Vu T, Nichols J, et al
    Predicted Coverage and Immuno-Safety of a Recombinant C-Repeat Region Based Streptococcus pyogenes Vaccine Candidate.
    PLoS One. 2016;11:e0156639.
    PubMed     Text format     Abstract available


  113. KILANY WH, Safwat M, Mohammed SM, Salim A, et al
    Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.
    PLoS One. 2016;11:e0156747.
    PubMed     Text format     Abstract available


  114. HEYDARCHI B, Center RJ, Gonelli C, Muller B, et al
    Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response.
    PLoS One. 2016;11:e0157353.
    PubMed     Text format     Abstract available


  115. GULLBERG M, Lohse L, Botner A, McInerney GM, et al
    A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    PLoS One. 2016;11:e0157435.
    PubMed     Text format     Abstract available


  116. SPENSIERI F, Siena E, Borgogni E, Zedda L, et al
    Early Rise of Blood T Follicular Helper Cell Subsets and Baseline Immunity as Predictors of Persisting Late Functional Antibody Responses to Vaccination in Humans.
    PLoS One. 2016;11:e0157066.
    PubMed     Text format     Abstract available


  117. CHANG YC, Tung HJ, Hsu SW, Chen LS, et al
    Use of Seasonal Influenza Vaccination and Its Associated Factors among Elderly People with Disabilities in Taiwan: A Population-Based Study.
    PLoS One. 2016;11:e0158075.
    PubMed     Text format     Abstract available


  118. YOON S, Kim ED, Song MS, Han SJ, et al
    Eyedrop Vaccination Induced Systemic and Mucosal Immunity against Influenza Virus in Ferrets.
    PLoS One. 2016;11:e0157634.
    PubMed     Text format     Abstract available


  119. HARVEY MJ, Prosser LA, Messonnier ML, Hutton DW, et al
    Hitting the Optimal Vaccination Percentage and the Risks of Error: Why to Miss Right.
    PLoS One. 2016;11:e0156737.
    PubMed     Text format     Abstract available


  120. FENG XM, Zheng WY, Zhang HM, Shi WY, et al
    Vaccination with Bivalent DNA Vaccine of alpha1-Giardin and CWP2 Delivered by Attenuated Salmonella typhimurium Reduces Trophozoites and Cysts in the Feces of Mice Infected with Giardia lamblia.
    PLoS One. 2016;11:e0157872.
    PubMed     Text format     Abstract available


  121. GREENBERG RN, Hay CM, Stapleton JT, Marbury TC, et al
    A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN(R)) in 56-80-Year-Old Subjects.
    PLoS One. 2016;11:e0157335.
    PubMed     Text format     Abstract available


  122. AKIN L, Macabeo B, Caliskan Z, Altinel S, et al
    Cost-Effectiveness of Increasing Influenza Vaccination Coverage in Adults with Type 2 Diabetes in Turkey.
    PLoS One. 2016;11:e0157657.
    PubMed     Text format     Abstract available


  123. HART PJ, O'Shaughnessy CM, Siggins MK, Bobat S, et al
    Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
    PLoS One. 2016;11:e0145945.
    PubMed     Text format     Abstract available


  124. RABINOWITZ M, Latella L, Stern C, Jost JT, et al
    Beliefs about Childhood Vaccination in the United States: Political Ideology, False Consensus, and the Illusion of Uniqueness.
    PLoS One. 2016;11:e0158382.
    PubMed     Text format     Abstract available


  125. THOMAS MA, Nyanhete T, Tuero I, Venzon D, et al
    Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector.
    PLoS One. 2016;11:e0158505.
    PubMed     Text format     Abstract available


  126. GILKEY MB, McRee AL, Magnus BE, Reiter PL, et al
    Vaccination Confidence and Parental Refusal/Delay of Early Childhood Vaccines.
    PLoS One. 2016;11:e0159087.
    PubMed     Text format     Abstract available


  127. MULLER L, Meyer M, Bauer RN, Zhou H, et al
    Effect of Broccoli Sprouts and Live Attenuated Influenza Virus on Peripheral Blood Natural Killer Cells: A Randomized, Double-Blind Study.
    PLoS One. 2016;11:e0147742.
    PubMed     Text format     Abstract available


  128. SCHIFFNER-ROHE J, Witt A, Hemmerling J, von Eiff C, et al
    Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk--A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0146338.
    PubMed     Text format     Abstract available


  129. CARDENAS-GARCIA S, Dunwoody RP, Marcano V, Diel DG, et al
    Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity.
    PLoS One. 2016;11:e0159153.
    PubMed     Text format     Abstract available


  130. HERMES R, Schwarzenberger F, Goritz F, Oh S, et al
    Ovarian down Regulation by GnRF Vaccination Decreases Reproductive Tract Tumour Size in Female White and Greater One-Horned Rhinoceroses.
    PLoS One. 2016;11:e0157963.
    PubMed     Text format     Abstract available


  131. BLANCO-HEREDIA J, Lecanda A, Valenzuela-Ponce H, Brander C, et al
    Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naive HIV-Infected Individuals.
    PLoS One. 2016;11:e0147571.
    PubMed     Text format     Abstract available


  132. CAO Y, Bansal GP, Merino K, Kumar N, et al
    Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses.
    PLoS One. 2016;11:e0158212.
    PubMed     Text format     Abstract available


  133. SPEAKE C, Pichugin A, Sahu T, Malkov V, et al
    Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
    PLoS One. 2016;11:e0159449.
    PubMed     Text format     Abstract available


  134. TRAVASSOS MA, Beyene B, Adam Z, Campbell JD, et al
    Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia.
    PLoS One. 2016;11:e0149970.
    PubMed     Text format     Abstract available


  135. NGABO F, Mvundura M, Gazley L, Gatera M, et al
    The Economic Burden Attributable to a Child's Inpatient Admission for Diarrheal Disease in Rwanda.
    PLoS One. 2016;11:e0149805.
    PubMed     Text format     Abstract available


  136. BOLLAERTS K, Shinde V, Dos Santos G, Ferreira G, et al
    Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix and Narcolepsy.
    PLoS One. 2016;11:e0149289.
    PubMed     Text format     Abstract available


  137. MANIGART O, Trotter C, Findlow H, Assefa A, et al
    A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
    PLoS One. 2016;11:e0147928.
    PubMed     Text format     Abstract available


  138. GOGOI-TIWARI J, Williams V, Waryah CB, Mathavan S, et al
    Intramammary Immunization of Pregnant Mice with Staphylococcal Protein A Reduces the Post-Challenge Mammary Gland Bacterial Load but Not Pathology.
    PLoS One. 2016;11:e0148383.
    PubMed     Text format     Abstract available


  139. CASARIN E, Lucchese L, Grazioli S, Facchin S, et al
    A New ELISA Using the ANANAS Technology Showing High Sensitivity to diagnose the Bovine Rhinotracheitis from Individual Sera to Pooled Milk.
    PLoS One. 2016;11:e0145912.
    PubMed     Text format     Abstract available


  140. PEDERSEN SR, Christensen JP, Buus S, Rasmussen M, et al
    Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides.
    PLoS One. 2016;11:e0145629.
    PubMed     Text format     Abstract available


  141. SUBHARAT S, Shu D, Zheng T, Buddle BM, et al
    Vaccination of Sheep with a Methanogen Protein Provides Insight into Levels of Antibody in Saliva Needed to Target Ruminal Methanogens.
    PLoS One. 2016;11:e0159861.
    PubMed     Text format     Abstract available


  142. LI M, Taylor EG, Atkins KE, Chapman GB, et al
    Stimulating Influenza Vaccination via Prosocial Motives.
    PLoS One. 2016;11:e0159780.
    PubMed     Text format     Abstract available


  143. SUZUKI Y, Odagiri T, Tashiro M, Nobusawa E, et al
    Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    PLoS One. 2016;11:e0160040.
    PubMed     Text format     Abstract available


  144. ZAMBONELLI C, Dey AK, Hilt S, Stephenson S, et al
    Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa.
    PLoS One. 2016;11:e0157391.
    PubMed     Text format     Abstract available


  145. REINTJES R, Das E, Klemm C, Richardus JH, et al
    "Pandemic Public Health Paradox": Time Series Analysis of the 2009/10 Influenza A / H1N1 Epidemiology, Media Attention, Risk Perception and Public Reactions in 5 European Countries.
    PLoS One. 2016;11:e0151258.
    PubMed     Text format     Abstract available


  146. TEN HAVE R, Reubsaet K, van Herpen P, Kersten G, et al
    Demonstrating Functional Equivalence of Pilot and Production Scale Freeze-Drying of BCG.
    PLoS One. 2016;11:e0151239.
    PubMed     Text format     Abstract available


  147. GONZALEZ-PENA D, Nixon SE, O'Connor JC, Southey BR, et al
    Microglia Transcriptome Changes in a Model of Depressive Behavior after Immune Challenge.
    PLoS One. 2016;11:e0150858.
    PubMed     Text format     Abstract available


  148. MUNANG'ANDU HM, Santi N, Fredriksen BN, Lokling KE, et al
    A Systematic Approach towards Optimizing a Cohabitation Challenge Model for Infectious Pancreatic Necrosis Virus in Atlantic Salmon (Salmo salar L.).
    PLoS One. 2016;11:e0148467.
    PubMed     Text format     Abstract available


  149. DANIELS-TREFFANDIER H, de Nie K, Marsay L, Dold C, et al
    Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.
    PLoS One. 2016;11:e0148840.
    PubMed     Text format     Abstract available


  150. LOMBARD R, Doz E, Carreras F, Epardaud M, et al
    IL-17RA in Non-Hematopoietic Cells Controls CXCL-1 and 5 Critical to Recruit Neutrophils to the Lung of Mycobacteria-Infected Mice during the Adaptive Immune Response.
    PLoS One. 2016;11:e0149455.
    PubMed     Text format     Abstract available


  151. MARIMON JM, Ercibengoa M, Tamayo E, Alonso M, et al
    Long-Term Epidemiology of Streptococcus pneumoniae Serogroup 6 in a Region of Southern Europe with Special Reference to Serotype 6E.
    PLoS One. 2016;11:e0149047.
    PubMed     Text format     Abstract available


  152. ALVARADO-FACUNDO E, Vassell R, Schmeisser F, Weir JP, et al
    Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies.
    PLoS One. 2016;11:e0149149.
    PubMed     Text format     Abstract available


  153. MUTURI-KIOI V, Lewis D, Launay O, Leroux-Roels G, et al
    Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review.
    PLoS One. 2016;11:e0157385.
    PubMed     Text format     Abstract available


  154. FELL DB, Wilson K, Ducharme R, Hawken S, et al
    Infant Respiratory Outcomes Associated with Prenatal Exposure to Maternal 2009 A/H1N1 Influenza Vaccination.
    PLoS One. 2016;11:e0160342.
    PubMed     Text format     Abstract available


  155. KUMAKECH E, Berggren V, Wabinga H, Lillsunde-Larsson G, et al
    Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix(R)) Pilot Project in Uganda.
    PLoS One. 2016;11:e0160099.
    PubMed     Text format     Abstract available


  156. ROTH A, Glaesener S, Schutz K, Meyer-Bahlburg A, et al
    Reduced Number of Transitional and Naive B Cells in Addition to Decreased BAFF Levels in Response to the T Cell Independent Immunogen Pneumovax(R)23.
    PLoS One. 2016;11:e0152215.
    PubMed     Text format     Abstract available


  157. GUPTA M, Angeli F, Bosma H, Rana M, et al
    Effectiveness of Multiple-Strategy Community Intervention in Reducing Geographical, Socioeconomic and Gender Based Inequalities in Maternal and Child Health Outcomes in Haryana, India.
    PLoS One. 2016;11:e0150537.
    PubMed     Text format     Abstract available


  158. VEGUILLA V, Lopez-Gatell H, Lopez-Martinez I, Aparicio-Antonio R, et al
    A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
    PLoS One. 2016;11:e0150428.
    PubMed     Text format     Abstract available


  159. KAWAHARA M, Hasegawa N, Takaku H
    Murine Splenic Natural Killer Cells Do Not Develop Immunological Memory after Re-Encounter with Mycobacterium bovis BCG.
    PLoS One. 2016;11:e0152051.
    PubMed     Text format     Abstract available


  160. MELO R, Richer L, Johnson DL, Gomes-Solecki M, et al
    Oral Immunization with OspC Does Not Prevent Tick-Borne Borrelia burgdorferi Infection.
    PLoS One. 2016;11:e0151850.
    PubMed     Text format     Abstract available


  161. MESHER D, Stanford E, White J, Findlow J, et al
    HPV Serology Testing Confirms High HPV Immunisation Coverage in England.
    PLoS One. 2016;11:e0150107.
    PubMed     Text format     Abstract available


  162. NORRIS A, Hachey K, Curtis A, Bourdeaux M, et al
    Crippling Violence: Conflict and Incident Polio in Afghanistan.
    PLoS One. 2016;11:e0149074.
    PubMed     Text format     Abstract available


  163. NGO CC, Massa HM, Thornton RB, Cripps AW, et al
    Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review.
    PLoS One. 2016;11:e0150949.
    PubMed     Text format     Abstract available


  164. DEL AMO E, Esteva C, Hernandez-Bou S, Galles C, et al
    Serotypes and Clonal Diversity of Streptococcus pneumoniae Causing Invasive Disease in the Era of PCV13 in Catalonia, Spain.
    PLoS One. 2016;11:e0151125.
    PubMed     Text format     Abstract available


  165. POSUWAN N, Wanlapakorn N, Sa-Nguanmoo P, Wasitthankasem R, et al
    The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation.
    PLoS One. 2016;11:e0150499.
    PubMed     Text format     Abstract available


  166. SZCZEPANEK SM, Roberts S, Rogers K, Cotte C, et al
    Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers.
    PLoS One. 2016;11:e0149261.
    PubMed     Text format     Abstract available


  167. XIONG W, Dong H, Wang J, Zou X, et al
    Analysis of Plasma Cytokine and Chemokine Profiles in Patients with and without Tuberculosis by Liquid Array-Based Multiplexed Immunoassays.
    PLoS One. 2016;11:e0148885.
    PubMed     Text format     Abstract available


  168. MCKINNEY BA, Lareau C, Oberg AL, Kennedy RB, et al
    The Integration of Epistasis Network and Functional Interactions in a GWAS Implicates RXR Pathway Genes in the Immune Response to Smallpox Vaccine.
    PLoS One. 2016;11:e0158016.
    PubMed     Text format     Abstract available


  169. PRAYGOD G, Mukerebe C, Magawa R, Jeremiah K, et al
    Indoor Air Pollution and Delayed Measles Vaccination Increase the Risk of Severe Pneumonia in Children: Results from a Case-Control Study in Mwanza, Tanzania.
    PLoS One. 2016;11:e0160804.
    PubMed     Text format     Abstract available


  170. HUMBERT MV, Hung MC, Phillips R, Akoto C, et al
    Vaccine Potential and Diversity of the Putative Cell Binding Factor (CBF, NMB0345/NEIS1825) Protein of Neisseria meningitidis.
    PLoS One. 2016;11:e0160403.
    PubMed     Text format     Abstract available


  171. MADAMPAGE CA, Wilson D, Townsend H, Crockford G, et al
    Cattle Immunized with a Recombinant Subunit Vaccine Formulation Exhibits a Trend towards Protection against Histophilus somni Bacterial Challenge.
    PLoS One. 2016;11:e0159070.
    PubMed     Text format     Abstract available


  172. GACH JS, Gorlani A, Dotsey EY, Becerra JC, et al
    HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects.
    PLoS One. 2016;11:e0160341.
    PubMed     Text format     Abstract available


  173. ANDERSON CS, DeDiego ML, Thakar J, Topham DJ, et al
    Novel Sequence-Based Mapping of Recently Emerging H5NX Influenza Viruses Reveals Pandemic Vaccine Candidates.
    PLoS One. 2016;11:e0160510.
    PubMed     Text format     Abstract available


  174. KESSANS SA, Linhart MD, Meador LR, Kilbourne J, et al
    Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.
    PLoS One. 2016;11:e0151842.
    PubMed     Text format     Abstract available


  175. PORTER CK, Riddle MS, Alcala AN, Sack DA, et al
    An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.
    PLoS One. 2016;11:e0149358.
    PubMed     Text format     Abstract available


  176. DEY A, Molodecky NA, Verma H, Sharma P, et al
    Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus.
    PLoS One. 2016;11:e0146010.
    PubMed     Text format     Abstract available


  177. HARALAMBIEVA IH, Zimmermann MT, Ovsyannikova IG, Grill DE, et al
    Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination.
    PLoS One. 2016;11:e0160970.
    PubMed     Text format     Abstract available


  178. VAN DER LINDEN M, Falkenhorst G, Perniciaro S, Fitzner C, et al
    Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany.
    PLoS One. 2016;11:e0161257.
    PubMed     Text format     Abstract available


  179. BILLESKOV R, Tan EV, Cang M, Abalos RM, et al
    Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis.
    PLoS One. 2016;11:e0161217.
    PubMed     Text format     Abstract available


  180. MAGINI D, Giovani C, Mangiavacchi S, Maccari S, et al
    Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge.
    PLoS One. 2016;11:e0161193.
    PubMed     Text format     Abstract available


  181. MALO CS, Renner DN, Huseby Kelcher AM, Jin F, et al
    The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma.
    PLoS One. 2016;11:e0162064.
    PubMed     Text format     Abstract available


  182. PATYKOWSKI J, Dell M, Gibson M
    Germination Ecology and Seed Dispersal of a Critically Endangered Plant: A Case Study of Pomaderris vacciniifolia (Round-Leaf Pomaderris).
    PLoS One. 2016;11:e0161665.
    PubMed     Text format     Abstract available


  183. RESENDE LA, Aguiar-Soares RD, Gama-Ker H, Roatt BM, et al
    Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.
    PLoS One. 2016;11:e0161169.
    PubMed     Text format     Abstract available


  184. LEE DH, Lee SH, Kim AR, Quan FS, et al
    Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii.
    PLoS One. 2016;11:e0161231.
    PubMed     Text format     Abstract available


  185. HOONAKKER ME, Verhagen LM, Pupo E, de Haan A, et al
    Vaccine-Mediated Activation of Human TLR4 Is Affected by Modulation of Culture Conditions during Whole-Cell Pertussis Vaccine Preparation.
    PLoS One. 2016;11:e0161428.
    PubMed     Text format     Abstract available


  186. LATASA C, Echeverz M, Garcia B, Gil C, et al
    Evaluation of a Salmonella Strain Lacking the Secondary Messenger C-di-GMP and RpoS as a Live Oral Vaccine.
    PLoS One. 2016;11:e0161216.
    PubMed     Text format     Abstract available


  187. CEBEY-LOPEZ M, Herberg J, Pardo-Seco J, Gomez-Carballa A, et al
    Does Viral Co-Infection Influence the Severity of Acute Respiratory Infection in Children?
    PLoS One. 2016;11:e0152481.
    PubMed     Text format     Abstract available


  188. KLAUSBERGER M, Tscheliessnig R, Neff S, Nachbagauer R, et al
    Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.
    PLoS One. 2016;11:e0153579.
    PubMed     Text format     Abstract available


  189. ZURAWSKI G, Zurawski S, Flamar AL, Richert L, et al
    Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.
    PLoS One. 2016;11:e0153484.
    PubMed     Text format     Abstract available


  190. QUAN V, Verani JR, Cohen C, von Gottberg A, et al
    Invasive Group B Streptococcal Disease in South Africa: Importance of Surveillance Methodology.
    PLoS One. 2016;11:e0152524.
    PubMed     Text format     Abstract available


  191. GUO Z, Xiao D, Li D, Wang X, et al
    Predicting and Evaluating the Epidemic Trend of Ebola Virus Disease in the 2014-2015 Outbreak and the Effects of Intervention Measures.
    PLoS One. 2016;11:e0152438.
    PubMed     Text format     Abstract available


  192. HAMMAMI P, Lancelot R, Lesnoff M
    Modelling the Dynamics of Post-Vaccination Immunity Rate in a Population of Sahelian Sheep after a Vaccination Campaign against Peste des Petits Ruminants Virus.
    PLoS One. 2016;11:e0161769.
    PubMed     Text format     Abstract available


  193. CHURCHYARD G, Mlisana K, Karuna S, Williamson AL, et al
    Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants.
    PLoS One. 2016;11:e0161753.
    PubMed     Text format     Abstract available


  194. ALI Z, Harastani H, Hammadi M, Reslan L, et al
    Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon.
    PLoS One. 2016;11:e0161345.
    PubMed     Text format     Abstract available


  195. KATIVHU CL, Libraty DH
    A Model to Explain How the Bacille Calmette Guerin (BCG) Vaccine Drives Interleukin-12 Production in Neonates.
    PLoS One. 2016;11:e0162148.
    PubMed     Text format     Abstract available


  196. TUNG IL, Machalek DA, Garland SM
    Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia.
    PLoS One. 2016;11:e0161846.
    PubMed     Text format     Abstract available


  197. WANG Z, Chen Y, Xie S, Lv H, et al
    Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults.
    PLoS One. 2016;11:e0153804.
    PubMed     Text format     Abstract available


  198. URANGA S, Marinova D, Martin C, Pardo J, et al
    Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In Vivo.
    PLoS One. 2016;11:e0153028.
    PubMed     Text format     Abstract available


  199. CHANTHAVILAY P, Reinharz D, Mayxay M, Phongsavan K, et al
    Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDR.
    PLoS One. 2016;11:e0162915.
    PubMed     Text format     Abstract available


  200. OLIVEIRA ER, Goncalves AJ, Costa SM, Azevedo AS, et al
    Aspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral Route.
    PLoS One. 2016;11:e0163240.
    PubMed     Text format     Abstract available


  201. NOH JY, Park JK, Lee DH, Yuk SS, et al
    Chimeric Bivalent Virus-Like Particle Vaccine for H5N1 HPAI and ND Confers Protection against a Lethal Challenge in Chickens and Allows a Strategy of Differentiating Infected from Vaccinated Animals (DIVA).
    PLoS One. 2016;11:e0162946.
    PubMed     Text format     Abstract available


  202. AYALA AJ, Dimitrov KM, Becker CR, Goraichuk IV, et al
    Presence of Vaccine-Derived Newcastle Disease Viruses in Wild Birds.
    PLoS One. 2016;11:e0162484.
    PubMed     Text format     Abstract available


  203. JUON HS, Strong C, Kim F, Park E, et al
    Lay Health Worker Intervention Improved Compliance with Hepatitis B Vaccination in Asian Americans: Randomized Controlled Trial.
    PLoS One. 2016;11:e0162683.
    PubMed     Text format     Abstract available


  204. MOLBAK K, Hansen ND, Valentiner-Branth P
    Pre-Vaccination Care-Seeking in Females Reporting Severe Adverse Reactions to HPV Vaccine. A Registry Based Case-Control Study.
    PLoS One. 2016;11:e0162520.
    PubMed     Text format     Abstract available


  205. MAMEDOV T, Chichester JA, Jones RM, Ghosh A, et al
    Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum.
    PLoS One. 2016;11:e0153956.
    PubMed     Text format     Abstract available


  206. NI G, Chen S, Yang Y, Cummins SF, et al
    Investigation the Possibility of Using Peptides with a Helical Repeating Pattern of Hydro-Phobic and Hydrophilic Residues to Inhibit IL-10.
    PLoS One. 2016;11:e0153939.
    PubMed     Text format     Abstract available


  207. TANMOY AM, Ahmed AN, Arumugam R, Hossain B, et al
    Rotavirus Surveillance at a WHO-Coordinated Invasive Bacterial Disease Surveillance Site in Bangladesh: A Feasibility Study to Integrate Two Surveillance Systems.
    PLoS One. 2016;11:e0153582.
    PubMed     Text format     Abstract available


  208. NJOM NLEND AE, Nguwoh PS, Ngounouh CT, Tchidjou HK, et al
    HIV-Infected or -Exposed Children Exhibit Lower Immunogenicity to Hepatitis B Vaccine in Yaounde, Cameroon: An Appeal for Revised Policies in Tropical Settings?
    PLoS One. 2016;11:e0161714.
    PubMed     Text format     Abstract available


  209. WONG LP, Raja Muhammad Yusoff RN, Edib Z, Sam IC, et al
    Nationwide Survey of Knowledge and Health Beliefs regarding Human Papillomavirus among HPV-Vaccinated Female Students in Malaysia.
    PLoS One. 2016;11:e0163156.
    PubMed     Text format     Abstract available


  210. KORAM KA, Adu B, Ocran J, Karikari YS, et al
    Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study.
    PLoS One. 2016;11:e0163066.
    PubMed     Text format     Abstract available


  211. SALK HM, Simon WL, Lambert ND, Kennedy RB, et al
    Taxa of the Nasal Microbiome Are Associated with Influenza-Specific IgA Response to Live Attenuated Influenza Vaccine.
    PLoS One. 2016;11:e0162803.
    PubMed     Text format     Abstract available


  212. POUWELS KB, Bozdemir SE, Yegenoglu S, Celebi S, et al
    Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data.
    PLoS One. 2016;11:e0163567.
    PubMed     Text format     Abstract available


  213. SPRUIJT IT, de Lange MM, Dijkstra F, Donker GA, et al
    Long-Term Correlation between Influenza Vaccination Coverage and Incidence of Influenza-Like Illness in 14 European Countries.
    PLoS One. 2016;11:e0163508.
    PubMed     Text format     Abstract available


  214. DHARMASENA MN, Feuille CM, Starke CE, Bhagwat AA, et al
    Development of an Acid-Resistant Salmonella Typhi Ty21a Attenuated Vector For Improved Oral Vaccine Delivery.
    PLoS One. 2016;11:e0163511.
    PubMed     Text format     Abstract available


  215. THOMPSON M, Heath SL, Sweeton B, Williams K, et al
    DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus.
    PLoS One. 2016;11:e0163164.
    PubMed     Text format     Abstract available


  216. ROUXEL RN, Merour E, Biacchesi S, Bremont M, et al
    Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines.
    PLoS One. 2016;11:e0164245.
    PubMed     Text format     Abstract available


  217. CHOI HG, Choi S, Back YW, Park HS, et al
    Mycobacterium tuberculosis Rv2882c Protein Induces Activation of Macrophages through TLR4 and Exhibits Vaccine Potential.
    PLoS One. 2016;11:e0164458.
    PubMed     Text format     Abstract available


  218. HADJIPANAYIS A, Efstathiou E, Alexandrou M, Panayiotou L, et al
    Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines.
    PLoS One. 2016;11:e0163269.
    PubMed     Text format     Abstract available


  219. SEDEGAH M, Peters B, Hollingdale MR, Ganeshan HD, et al
    Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
    PLoS One. 2016;11:e0163026.
    PubMed     Text format     Abstract available


  220. FABER BW, Hellwig S, Houard S, Havelange N, et al
    Production, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation.
    PLoS One. 2016;11:e0164053.
    PubMed     Text format     Abstract available


  221. HARRISON D, Wilding J, Bowman A, Fuller A, et al
    Using YouTube to Disseminate Effective Vaccination Pain Treatment for Babies.
    PLoS One. 2016;11:e0164123.
    PubMed     Text format     Abstract available


  222. SPEAKE C, Pichugin A, Sahu T, Malkov V, et al
    Correction: Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
    PLoS One. 2016;11:e0165489.
    PubMed     Text format     Abstract available


  223. FLYNN JA, Durr E, Swoyer R, Cejas PJ, et al
    Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein.
    PLoS One. 2016;11:e0164789.
    PubMed     Text format     Abstract available


  224. XIE J, Codd C, Mo K, He Y, et al
    Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis.
    PLoS One. 2016;11:e0164792.
    PubMed     Text format     Abstract available


  225. TALAAT KR, Ellis RD, Hurd J, Hentrich A, et al
    Safety and Immunogenicity of Pfs25-EPA/Alhydrogel(R), a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naive Adults.
    PLoS One. 2016;11:e0163144.
    PubMed     Text format     Abstract available


  226. COLLINSON-PAUTZ MR, Slawin KM, Levitt JM, Spencer DM, et al
    MyD88/CD40 Genetic Adjuvant Function in Cutaneous Atypical Antigen-Presenting Cells Contributes to DNA Vaccine Immunogenicity.
    PLoS One. 2016;11:e0164547.
    PubMed     Text format     Abstract available


  227. PATEL MC, Wang W, Pletneva LM, Rajagopala SV, et al
    Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus).
    PLoS One. 2016;11:e0166336.
    PubMed     Text format     Abstract available


  228. LAZARUS R, Kelly S, Snape MD, Vandermeulen C, et al
    Antibody Persistence and Booster Responses to Split-Virion H5N1 Avian Influenza Vaccine in Young and Elderly Adults.
    PLoS One. 2016;11:e0165384.
    PubMed     Text format     Abstract available


  229. LEE D, Park SM
    Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination.
    PLoS One. 2016;11:e0165879.
    PubMed     Text format     Abstract available


  230. GUPTA S, Chaudhary K, Dhanda SK, Kumar R, et al
    A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer.
    PLoS One. 2016;11:e0166372.
    PubMed     Text format     Abstract available


  231. FABIANI M, Riccardo F, Di Napoli A, Gargiulo L, et al
    Differences in Influenza Vaccination Coverage between Adult Immigrants and Italian Citizens at Risk for Influenza-Related Complications: A Cross-Sectional Study.
    PLoS One. 2016;11:e0166517.
    PubMed     Text format     Abstract available


  232. KAMBIRE D, Soeters HM, Ouedraogo-Traore R, Medah I, et al
    Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.
    PLoS One. 2016;11:e0166384.
    PubMed     Text format     Abstract available


  233. MINCHOLE E, Figueredo AL, Omenaca M, Panadero C, et al
    Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People.
    PLoS One. 2016;11:e0165711.
    PubMed     Text format     Abstract available


  234. LINDSTRAND A, Kalyango J, Alfven T, Darenberg J, et al
    Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate?
    PLoS One. 2016;11:e0166018.
    PubMed     Text format     Abstract available


  235. WANG Y, Vlasova A, Velasquez DE, Saif LJ, et al
    Skin Vaccination against Rotavirus Using Microneedles: Proof of Concept in Gnotobiotic Piglets.
    PLoS One. 2016;11:e0166038.
    PubMed     Text format     Abstract available


  236. COTE-GRAVEL J, Brouillette E, Obradovic N, Ster C, et al
    Characterization of a vraG Mutant in a Genetically Stable Staphylococcus aureus Small-Colony Variant and Preliminary Assessment for Use as a Live-Attenuated Vaccine against Intrammamary Infections.
    PLoS One. 2016;11:e0166621.
    PubMed     Text format     Abstract available


  237. AHONKHAI V, Martins SF, Portet A, Lumpkin M, et al
    Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.
    PLoS One. 2016;11:e0166515.
    PubMed     Text format     Abstract available


  238. FLOOD A, Estrada M, McAdams D, Ji Y, et al
    Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation.
    PLoS One. 2016;11:e0164692.
    PubMed     Text format     Abstract available


  239. BALDO V, Cocchio S, Gallo T, Furlan P, et al
    Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
    PLoS One. 2016;11:e0166637.
    PubMed     Text format     Abstract available


  240. CARVALHO TF, Haddad JP, Paixao TA, Santos RL, et al
    Meta-Analysis and Advancement of Brucellosis Vaccinology.
    PLoS One. 2016;11:e0166582.
    PubMed     Text format     Abstract available


  241. CRANK MC, Wilson EM, Novik L, Enama ME, et al
    Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012).
    PLoS One. 2016;11:e0166393.
    PubMed     Text format     Abstract available


  242. ROMLEY J, Goutam P, Sood N
    National Survey Indicates that Individual Vaccination Decisions Respond Positively to Community Vaccination Rates.
    PLoS One. 2016;11:e0166858.
    PubMed     Text format     Abstract available


  243. NUNES AM, Ribeiro GS, Ferreira IE, Moura AR, et al
    Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil.
    PLoS One. 2016;11:e0166475.
    PubMed     Text format     Abstract available


  244. RASHID S, Labani S, Das BC
    Knowledge, Awareness and Attitude on HPV, HPV Vaccine and Cervical Cancer among the College Students in India.
    PLoS One. 2016;11:e0166713.
    PubMed     Text format     Abstract available


  245. HILLS T, Jakeman PG, Carlisle RC, Klenerman P, et al
    A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation.
    PLoS One. 2016;11:e0166383.
    PubMed     Text format     Abstract available


  246. VOINSON M, Billiard S, Alvergne A
    Correction: Beyond Rational Decision-Making: Modelling the Influence of Cognitive Biases on the Dynamics of Vaccination Coverage.
    PLoS One. 2016;11:e0167842.
    PubMed     Text format     Abstract available


  247. TRYFINOPOULOU K, Kesanopoulos K, Xirogianni A, Marmaras N, et al
    Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015).
    PLoS One. 2016;11:e0167404.
    PubMed     Text format     Abstract available


  248. NUGENT G, Yockney IJ, Whitford EJ, Cross ML, et al
    Field Trial of an Aerially-Distributed Tuberculosis Vaccine in a Low-Density Wildlife Population of Brushtail Possums (Trichosurus vulpecula).
    PLoS One. 2016;11:e0167144.
    PubMed     Text format     Abstract available


  249. BENARD A, Sala C, Pluschke G
    Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates.
    PLoS One. 2016;11:e0167059.
    PubMed     Text format     Abstract available


  250. NJOKU OS, Manak MM, O'Connell RJ, Shutt AL, et al
    An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria.
    PLoS One. 2016;11:e0166711.
    PubMed     Text format     Abstract available


  251. ZHENG X, Zhang N, Zhang X, Hao L, et al
    Correction: Investigation of a Measles Outbreak in China to Identify Gaps in Vaccination Coverage, Routes of Transmission, and Interventions.
    PLoS One. 2016;11:e0168222.
    PubMed     Text format     Abstract available


  252. GUNNALA R, Ogbuanu IU, Adegoke OJ, Scobie HM, et al
    Routine Vaccination Coverage in Northern Nigeria: Results from 40 District-Level Cluster Surveys, 2014-2015.
    PLoS One. 2016;11:e0167835.
    PubMed     Text format     Abstract available


  253. SAMMER D, Krause K, Gube M, Wagner K, et al
    Hydrophobins in the Life Cycle of the Ectomycorrhizal Basidiomycete Tricholoma vaccinum.
    PLoS One. 2016;11:e0167773.
    PubMed     Text format     Abstract available


  254. MENSAH VA, Gueye A, Ndiaye M, Edwards NJ, et al
    Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal.
    PLoS One. 2016;11:e0167951.
    PubMed     Text format     Abstract available


  255. VIARD JP, Assuied A, Levy Y, Souberbielle JC, et al
    No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults.
    PLoS One. 2016;11:e0168640.
    PubMed     Text format     Abstract available


  256. WANG B, Russell ML, Moss L, Fonseca K, et al
    Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial.
    PLoS One. 2016;11:e0167281.
    PubMed     Text format     Abstract available


  257. DALZON B, Lebas C, Jimenez G, Gutjahr A, et al
    Poly(Lactic Acid) Nanoparticles Targeting alpha5beta1 Integrin as Vaccine Delivery Vehicle, a Prospective Study.
    PLoS One. 2016;11:e0167663.
    PubMed     Text format     Abstract available


  258. YASUDA T, Ura T, Taniguchi M, Yoshida H, et al
    Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy.
    PLoS One. 2016;11:e0167952.
    PubMed     Text format     Abstract available


  259. DE OLIVEIRA LH, Camacho LA, Coutinho ES, Martinez-Silveira MS, et al
    Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review.
    PLoS One. 2016;11:e0166736.
    PubMed     Text format     Abstract available


  260. WONG C, Jiang M, You JH
    Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children.
    PLoS One. 2016;11:e0169030.
    PubMed     Text format     Abstract available


  261. LAMBKIN-WILLIAMS R, Gelder C, Broughton R, Mallett CP, et al
    An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Inf
    PLoS One. 2016;11:e0163089.
    PubMed     Text format     Abstract available


  262. TOTA JE, Jiang M, Ramanakumar AV, Walter SD, et al
    Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination.
    PLoS One. 2016;11:e0166329.
    PubMed     Text format     Abstract available



  263. Correction: A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    PLoS One. 2016;11:e0169025.
    PubMed     Text format     Abstract available


  264. MBUNDA T, Tarimo EA, Chalamilla G, Bakari M, et al
    The Influence of Community Members on Participation by Youth in an HIV Vaccine Trial in Tanzania.
    PLoS One. 2016;11:e0168660.
    PubMed     Text format     Abstract available


  265. SEDEGAH M, Peters B, Hollingdale MR, Ganeshan HD, et al
    Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes.
    PLoS One. 2016;11:e0168952.
    PubMed     Text format     Abstract available


  266. LAHEY T, Laddy D, Hill K, Schaeffer J, et al
    Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.
    PLoS One. 2016;11:e0168521.
    PubMed     Text format     Abstract available


  267. ROSSI R, Assaad R, Rebeschini A, Hamadeh R, et al
    Vaccination Coverage Cluster Surveys in Middle Dreib - Akkar, Lebanon: Comparison of Vaccination Coverage in Children Aged 12-59 Months Pre- and Post-Vaccination Campaign.
    PLoS One. 2016;11:e0168145.
    PubMed     Text format     Abstract available


  268. DANGOR Z, Cutland CL, Izu A, Kwatra G, et al
    Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development.
    PLoS One. 2016;11:e0169101.
    PubMed     Text format     Abstract available


  269. JONES C, Sadarangani M, Lewis S, Payne I, et al
    Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells.
    PLoS One. 2016;11:e0154153.
    PubMed     Text format     Abstract available


  270. ZHAO L, Mahony D, Cavallaro AS, Zhang B, et al
    Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.
    PLoS One. 2016;11:e0154295.
    PubMed     Text format     Abstract available


    January 2015
  271. PREVATO M, Ferlenghi I, Bonci A, Uematsu Y, et al
    Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay.
    PLoS One. 2015;10:e0135474.
    PubMed     Text format     Abstract available


  272. DENG K, Liu R, Rao H, Jiang D, et al
    Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.
    PLoS One. 2015;10:e0138756.
    PubMed     Text format     Abstract available


  273. CHOI SJ, Kim MH, Jeon J, Kim OY, et al
    Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity.
    PLoS One. 2015;10:e0136021.
    PubMed     Text format     Abstract available


  274. VAN DIJK CE, Hooiveld M, Jentink A, Isken LD, et al
    Experiences of General Practitioners and Practice Assistants during the Influenza A(H1N1) Pandemic in the Netherlands: A Cross-Sectional Survey.
    PLoS One. 2015;10:e0135666.
    PubMed     Text format     Abstract available


  275. POTEET E, Lewis P, Li F, Zhang S, et al
    A Novel Prime and Boost Regimen of HIV Virus-Like Particles with TLR4 Adjuvant MPLA Induces Th1 Oriented Immune Responses against HIV.
    PLoS One. 2015;10:e0136862.
    PubMed     Text format     Abstract available


  276. BILLINGS E, Sanders-Buell E, Bose M, Bradfield A, et al
    The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.
    PLoS One. 2015;10:e0135124.
    PubMed     Text format     Abstract available


  277. JEYANATHAN M, Shao Z, Yu X, Harkness R, et al
    AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
    PLoS One. 2015;10:e0135009.
    PubMed     Text format     Abstract available


  278. TEWAWONG N, Prachayangprecha S, Vichiwattana P, Korkong S, et al
    Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses.
    PLoS One. 2015;10:e0139958.
    PubMed     Text format     Abstract available


  279. ADETIFA IM, Muhammad AK, Jeffries D, Donkor S, et al
    A Tuberculin Skin Test Survey and the Annual Risk of Mycobacterium tuberculosis Infection in Gambian School Children.
    PLoS One. 2015;10:e0139354.
    PubMed     Text format     Abstract available


  280. JONES-LOPEZ EC, White LF, Kirenga B, Mumbowa F, et al
    Cough Aerosol Cultures of Mycobacterium tuberculosis: Insights on TST / IGRA Discordance and Transmission Dynamics.
    PLoS One. 2015;10:e0138358.
    PubMed     Text format     Abstract available


  281. CHA SB, Kim WS, Kim JS, Kim H, et al
    Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    PLoS One. 2015;10:e0141577.
    PubMed     Text format     Abstract available


  282. LEE YN, Kim MC, Lee YT, Hwang HS, et al
    Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.
    PLoS One. 2015;10:e0137822.
    PubMed     Text format     Abstract available


  283. OZEKI Y, Igarashi M, Doe M, Tamaru A, et al
    A New Screen for Tuberculosis Drug Candidates Utilizing a Luciferase-Expressing Recombinant Mycobacterium bovis Bacillus Calmette-Gueren.
    PLoS One. 2015;10:e0141658.
    PubMed     Text format     Abstract available


  284. WANG PC, Mwango A, Moberley S, Brockman BJ, et al
    A Cluster Randomised Trial on the Impact of Integrating Early Infant HIV Diagnosis with the Expanded Programme on Immunization on Immunization and HIV Testing Rates in Rural Health Facilities in Southern Zambia.
    PLoS One. 2015;10:e0141455.
    PubMed     Text format     Abstract available


  285. BADAMCHI-ZADEH A, McKay PF, Holland MJ, Paes W, et al
    Intramuscular Immunisation with Chlamydial Proteins Induces Chlamydia trachomatis Specific Ocular Antibodies.
    PLoS One. 2015;10:e0141209.
    PubMed     Text format     Abstract available


  286. WEBBY RJ, Weaver EA
    Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses.
    PLoS One. 2015;10:e0140702.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: